The mechanisms of wine phenolic compounds for preclinical anticancer therapeutics
Open Access
- 23 August 2021
- journal article
- research article
- Published by SNF Swedish Nutrition Foundation in Food & Nutrition Research
Abstract
Background: Wine is one of the oldest and most popular drinks worldwide, which is rich in phenolic compounds. Epidemiological studies show that moderate consumption of wine can reduce the risk of certain diseases, and this effect is attributed to its phenolic compounds. Objective: The objective of this review was to elaborate the effects of wine-derived phenolic compounds for preclinical anticancer therapeutics and their major mechanisms. Methods: In this review, we discuss the classification and content of common phenolic compounds in wine and summarize previous studies that have evaluated the anticancer properties of wine-derived phenolic compounds and their mechanisms. Results: Wine-derived phenolic compounds have been proven to participate in several mechanisms against cancers, including deoxyribonucleic acid damage, oxidative stress, cell proliferation, cell cycle arrest, cell apoptosis, autophagy, cell invasion and metastasis, immunity and metabolism, regulation of multiple signaling molecules, and gene expression. However, the exact anticancer mechanisms of the phenolic compounds in wine need to be further investigated. Conclusion: Wine-derived phenolic compounds are promising chemoprotective and chemotherapeutic agents for cancer.Keywords
This publication has 158 references indexed in Scilit:
- Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applicationsFood & Function, 2013
- Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) studyThe American Journal of Clinical Nutrition, 2012
- Wine, Beer, Alcohol and Polyphenols on Cardiovascular Disease and CancerNutrients, 2012
- Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysisBMJ, 2011
- NF-κB, Inflammation, and Metabolic DiseaseCell Metabolism, 2011
- The Biological Responses to Resveratrol and Other Polyphenols From Alcoholic BeveragesAlcohol: Clinical and Experimental Research, 2009
- Effects of low dose quercetin: Cancer cell‐specific inhibition of cell cycle progressionJournal of Cellular Biochemistry, 2008
- Oral squamous cell carcinoma proliferative phenotype is modulated by proanthocyanidins: a potential prevention and treatment alternative for oral cancerBMC Complementary and Alternative Medicine, 2007
- Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetablesLife Sciences, 2005
- Survivin and p53 Modulate Quercetin-induced Cell Growth Inhibition and Apoptosis in Human Lung Carcinoma CellsOnline Journal of Public Health Informatics, 2004